It regulates migration and invasion in breast cancer through MyoGEF–Cdc42–MMP9 signaling, facilitates ECM remodeling via interactions with neuropilin-1 and α5β1 integrin, and sustains receptor trafficking in glioma and melanoma. Here, MMP9 is linked to breast carcinoma.